Captopril, an Angiotensin-Converting Enzyme Inhibitor, Promotes Growth of Immunogenic Tumors in Mice
Open Access
- 1 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (13), 4095-4102
- https://doi.org/10.1158/1078-0432.ccr-05-2489
Abstract
Purpose: Antitumor potential of angiotensin-converting enzyme inhibitors has been shown in different preclinical settings, which always involved immunocompromised organisms or nonimmunogenic tumor models. In our study, we wanted to evaluate the effect of captopril on growth of immunogenic tumors in immunocompetent animals.Keywords
This publication has 39 references indexed in Scilit:
- Association between captopril, other antihypertensive drugs and risk of prostate cancerThe Prostate, 2003
- Activation and suppression of renin–angiotensin system in human dendritic cellsBiochemical and Biophysical Research Communications, 2002
- Tumor Eradication by Wild-type p53-specific Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1997
- An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancerThe Prostate, 1994
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experienceArchives of Internal Medicine, 1994
- Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trialsInternational Journal of Cardiology, 1994
- The effect of Captopril on benign and malignant reactions in irradiated rat skinThe British Journal of Radiology, 1990
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Captopril and immune regulationKidney International, 1984